A Phase IV, Open-Label, Randomized, Active-controlled, Single-Center Study of ZYNRELEF ® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy
Conditions: Post Operative Pain, Acute; Bariatric Surgery Candidate; Postoperative Pain; Postoperative Opioid Use in Bariatric Surgery Intervention: Drug: ZYNRELEF 200Mg-6Mg Extended-Release Solution Sponsors: Dr. Yannis Raftopoulos; Heron Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials